Formulation and delivery solutions for the next generation biotherapeutics

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In 2018 I was appointed full professor of Pharmaceutical Biotechnology & Delivery at the Pharmaceutics division of the department of Pharmaceutical Sciences at Utrecht University, The Netherlands. In this contribution to the Orations - New Horizons of the Journal of Controlled Release I will introduce my research group (see also www.uu.nl/pharmaceutics) and will highlight my current and future research projects. In coming years the focus of my research will be on the administration of biotherapeutics, aiming to control their fate from the site of injection to the site of action. I will discuss issues related to formulation of biotherapeutics into nanomedicines (NMs), intracellular delivery of nucleic acids as well as protein therapeutics, and targeted delivery of biotherapeutics beyond the liver. In addition, I will provide a forward view on how current developments in the drug delivery and gene therapy field may result in sustainable and cost-effective dosing regimens for biotherapeutics.

Original languageEnglish
Pages (from-to)583-597
Number of pages15
JournalJournal of controlled release : official journal of the Controlled Release Society
Volume336
DOIs
Publication statusPublished - 10 Aug 2021

Bibliographical note

Copyright © 2021 The Author. Published by Elsevier B.V. All rights reserved.

Keywords

  • Drug Delivery Systems
  • Humans
  • Nanomedicine
  • Netherlands
  • Pharmaceutical Preparations

Fingerprint

Dive into the research topics of 'Formulation and delivery solutions for the next generation biotherapeutics'. Together they form a unique fingerprint.

Cite this